Alpha Fetoprotein, Total and L3 Percent
Commercial Mail-out Laboratory
|Red top tube 5 mL (Clot Activator)
Preferred Minimum: 1 mL serum
Absolute Minimum: 0.5 mL serum
1-5 days upon receipt at reference laboratory
The μTASWako method is used. Results obtained with different assay
methods or kits cannot be used interchangeably. The AFP L3 Percent
assay is intended as a risk assessment for the development of
hepatocellular carcinoma in patients with chronic liver diseases.
Patients with elevated serum AFP-L3 percent should be more intensely
evaluated for evidence of hepatocellular carcinoma since elevated
values have been shown to be associated with a seven-fold increase in
the risk for developing hepatocellular carcinoma within 21 months. For
pregnant females, the result is not interpretable as a tumor marker.
Quantitative Liquid Chromatography/Immunoassay